HelenaRChangMD
General Surgery • Los Angeles, CABreast, Surgical Oncology (Other than Breast)
Professor of Surgery, UCLA
Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 UCLA Medical Plz
Ste 310
Los Angeles, CA 90024Phone+1 310-825-2144Fax+1 310-206-2982
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 1986 - 1988
Episcopal HospitalResidency, Surgery, 1981 - 1986
Lewis Katz School of Medicine at Temple UniversityClass of 1981
Certifications & Licensure
NY State Medical License 1986 - Present
CA State Medical License 1988 - 2023
RI State Medical License 1991 - 1998
PA State Medical License 1983 - 1988- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer Start of enrollment: 1999 Jan 01
- Cryosurgery in Treating Women With Breast Lesions Start of enrollment: 2001 May 01
- Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer Start of enrollment: 2003 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer.Ann M Chan, Brian Aguirre, Lucia Liu, Vei Mah, Justin M Balko
Cancers. 2024-04-12 - 3 citationsA Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer.Vina P Nguyen, Katie M Campbell, Theodore S Nowicki, Nila Elumalai, Egmidio Medina
Cancer Research Communications. 2023-08-01 - 28 citationsHCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma.Na Sun, Ceng Zhang, Yi-Te Lee, Benjamin V Tran, Jing Wang
Hepatology. 2023-03-01
Press Mentions
12 Exciting Cancer Breakthroughs You Should Know AboutOctober 3rd, 2014
Grant Support
- Ethnicity-Based Proteomic Biomarkers In Breast CancerNational Cancer Institute2002–2004
- Generation Of Mabs Against Pancreatic CancerNational Cancer Institute1994–1996
- Generation Of Human Mabs Against Pancreatic CancerNational Cancer Institute1992–1993
Professional Memberships
- Member
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
